Cargando…
The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO
Gliomas have been histologically diagnosed as the third most common primary tumor of the central nervous system (CNS) in a relatively small portion of Korea. Despite the rarity of gliomas, the disease entity is very dynamic due to its various molecular characteristics, compared with other CNS tumors...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098981/ https://www.ncbi.nlm.nih.gov/pubmed/35545827 http://dx.doi.org/10.14791/btrt.2022.0001 |
_version_ | 1784706501447778304 |
---|---|
author | Kim, Young Zoon Kim, Chae-Yong Lim, Do Hoon |
author_facet | Kim, Young Zoon Kim, Chae-Yong Lim, Do Hoon |
author_sort | Kim, Young Zoon |
collection | PubMed |
description | Gliomas have been histologically diagnosed as the third most common primary tumor of the central nervous system (CNS) in a relatively small portion of Korea. Despite the rarity of gliomas, the disease entity is very dynamic due to its various molecular characteristics, compared with other CNS tumors. The practice of managing glioma patients is not globally established as a precise standard guideline because of the different socio-medical environments of individual countries. The Korean Society for Neuro-Oncology (KSNO) published guidelines for managing adult glioma in 2019, and the National Comprehensive Cancer Network and European Association of Neuro-Oncology published guidelines in September 2021 and March 2021, respectively. However, these guidelines have several different recommendations in practice, including tissue management, adjuvant treatment after surgical resection, and salvage treatment for recurrent/progressive gliomas. Currently, the KSNO guideline working group is preparing an updated version of the guideline for managing adult gliomas. In this review, common features have been verified and different points are analyzed. Consequently, this review is expected to be informative and helpful to provide high quality evidence and a strong recommendation level for the establishment of new KSNO guidelines for managing gliomas. |
format | Online Article Text |
id | pubmed-9098981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-90989812022-05-19 The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO Kim, Young Zoon Kim, Chae-Yong Lim, Do Hoon Brain Tumor Res Treat Review Article Gliomas have been histologically diagnosed as the third most common primary tumor of the central nervous system (CNS) in a relatively small portion of Korea. Despite the rarity of gliomas, the disease entity is very dynamic due to its various molecular characteristics, compared with other CNS tumors. The practice of managing glioma patients is not globally established as a precise standard guideline because of the different socio-medical environments of individual countries. The Korean Society for Neuro-Oncology (KSNO) published guidelines for managing adult glioma in 2019, and the National Comprehensive Cancer Network and European Association of Neuro-Oncology published guidelines in September 2021 and March 2021, respectively. However, these guidelines have several different recommendations in practice, including tissue management, adjuvant treatment after surgical resection, and salvage treatment for recurrent/progressive gliomas. Currently, the KSNO guideline working group is preparing an updated version of the guideline for managing adult gliomas. In this review, common features have been verified and different points are analyzed. Consequently, this review is expected to be informative and helpful to provide high quality evidence and a strong recommendation level for the establishment of new KSNO guidelines for managing gliomas. The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 2022-04 2022-04-29 /pmc/articles/PMC9098981/ /pubmed/35545827 http://dx.doi.org/10.14791/btrt.2022.0001 Text en Copyright © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Kim, Young Zoon Kim, Chae-Yong Lim, Do Hoon The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO |
title | The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO |
title_full | The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO |
title_fullStr | The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO |
title_full_unstemmed | The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO |
title_short | The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO |
title_sort | overview of practical guidelines for gliomas by ksno, nccn, and eano |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098981/ https://www.ncbi.nlm.nih.gov/pubmed/35545827 http://dx.doi.org/10.14791/btrt.2022.0001 |
work_keys_str_mv | AT kimyoungzoon theoverviewofpracticalguidelinesforgliomasbyksnonccnandeano AT kimchaeyong theoverviewofpracticalguidelinesforgliomasbyksnonccnandeano AT limdohoon theoverviewofpracticalguidelinesforgliomasbyksnonccnandeano AT kimyoungzoon overviewofpracticalguidelinesforgliomasbyksnonccnandeano AT kimchaeyong overviewofpracticalguidelinesforgliomasbyksnonccnandeano AT limdohoon overviewofpracticalguidelinesforgliomasbyksnonccnandeano |